Monday, June 28, 2021
11:34 AM EST – Crescita Therapeutics Inc. : Has entered into an exclusive commercialization and development license agreement with Croma Pharma GmbH, a globally acclaimed pharmaceutical company with specializations in medical aesthetics, ophthalmology and orthopaedics for the rights to Pliaglis® in nine countries including Germany, the United Kingdom, Ireland, Switzerland, Brazil, Romania, Belgium, the Netherlands and Luxembourg. Crescita Therapeutics Inc.
(T.CTX ) shares were up $0.05 at 0.79.
Stocks in Play: Crescita Therapeutics Inc., Mon, 28 Jun 2021 11:42:11 EST